Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Bacteriophage Therapy for UTI
NCT04287478Phase 2Terminated
- Sponsor
- BiomX
- Start
- Dec 2020
- Primary completion
- Feb 2023
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of PhageBank in urinary tract infection (UTI), sponsored by BiomX. Started Dec 2020; status: terminated.
02
Drugs
PhageBank
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04287478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04287478.